• SPX
  • $5,888.73
  • -0.48 %
  • -$28.38
  • DJI
  • $43,533.76
  • 0.29 %
  • $125.28
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,129.60
  • 0.55 %
  • $44.53
  • IXIC
  • $18,719.83
  • -1.3 %
  • -$246.31
MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, News & Analysis

MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, News & Analysis

Currency in USD Disclaimer

$1.22

-$0.05

(-3.6%)

Day's range
$1.2
Day's range
$1.33
50-day range
$1.02
Day's range
$2.56
  • Country: US
  • ISIN: US60458C1045
52 wk range
$0.51
Day's range
$5.01


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 5.53
  • Piotroski Score 1.00
  • Grade N/A
  • Symbol (MIRA)
  • Company MIRA Pharmaceuticals, Inc.
  • Price $1.22
  • Changes Percentage (-3.6%)
  • Change -$0.05
  • Day Low $1.20
  • Day High $1.33
  • Year High $5.01

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.66
  • Trailing P/E Ratio -1.15
  • Forward P/E Ratio -1.15
  • P/E Growth -1.15
  • Net Income $-11,982,343

Income Statement

Quarterly

Annual

Latest News of MIRA

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

MIRA Pharmaceuticals, Inc. Frequently Asked Questions

  • What were the earnings of MIRA in the last quarter?

    In the last quarter MIRA Pharmaceuticals, Inc. earnings were on Tuesday, November, 12th. The MIRA Pharmaceuticals, Inc. maker reported -$0.14 EPS for the quarter, beating analysts' consensus estimates of -$0.18 by $0.04.

  • What is the MIRA Pharmaceuticals, Inc. stock price today?

    Today's price of MIRA Pharmaceuticals, Inc. is $1.22 — it has decreased by -3.6% in the past 24 hours. Watch MIRA Pharmaceuticals, Inc. stock price performance more closely on the chart.

  • Does MIRA Pharmaceuticals, Inc. release reports?

    Yes, you can track MIRA Pharmaceuticals, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the MIRA Pharmaceuticals, Inc. stock forecast?

    Watch the MIRA Pharmaceuticals, Inc. chart and read a more detailed MIRA Pharmaceuticals, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is MIRA Pharmaceuticals, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by MIRA Pharmaceuticals, Inc. stock ticker.

  • How to buy MIRA Pharmaceuticals, Inc. stocks?

    Like other stocks, MIRA shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is MIRA Pharmaceuticals, Inc.'s EBITDA?

    MIRA Pharmaceuticals, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in MIRA Pharmaceuticals, Inc.’s financial statements.

  • What is the MIRA Pharmaceuticals, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in MIRA Pharmaceuticals, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including MIRA Pharmaceuticals, Inc.'s financials relevant news, and technical analysis. MIRA Pharmaceuticals, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for MIRA Pharmaceuticals, Inc. stock currently indicates a “sell” signal. For more insights, review MIRA Pharmaceuticals, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.